A clinical-stage biopharmaceutical company focused on applying our novel Hierotope™ platform to identify unique disease targets and to design and engineer innovative antibody-based therapies that are intended to be effective as a single-dose administration.
Lead Underwriter
Leerink Partners LLC,Stifel Nicolaus & Company, Incorporated
